在炎症性肠病中的益生菌:微生物调制和治疗前景
Omar P Vallejos1, Susan M Bueno1, Alexis M Kalergis2
1Millennium Institute of Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
Trends in molecular medicine
|January 15, 2025
概括
益生菌显示出通过调节肠道微生物群和减少炎症来管理炎症性肠病 (IBD) 的潜力. 需要进一步的研究,才能充分理解它们在IBD中的治疗机制.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD) 是一种慢性多因素性疾病,对全球健康有重大影响.
- 遗传,环境,免疫和微生物因素之间的复杂相互作用有助于IBD的发病.
- 肠道微生物群在维持肠道平衡和免疫功能方面发挥着至关重要的作用.
研究的目的:
- 探索益生菌在治疗炎症性肠病 (IBD) 的治疗潜力.
- 审查益生菌可以缓解IBD相关炎症的机制.
- 突出益生菌作为IBD管理的新方法.
主要方法:
- 在IBD的背景下研究益生菌的研究文献综述.
- 对益生菌机制的研究分析,包括微生物群调节,基因组胺调节和维生素D代谢.
- 综合关于益生菌免疫调节作用的证据.
主要成果:
- 益生菌在调节肠道微生物群的组成和功能方面表现有前途.
- 有证据表明,益生菌可以调节胰岛素水平,增强维生素D的新陈代谢.
- 这些作用有助于更耐受的免疫特征和减少肠道炎症.
结论:
- 益生菌代表了炎症性肠病 (IBD) 的有前途的治疗策略.
- 机制包括肠道微生物群调节,免疫调节和增强的维生素D代谢.
- 需要进一步的研究,以充分阐明潜在的机制,并优化益生菌在IBD治疗中的使用.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110
Inflammatory Bowel Disease V: Surgical Management
115
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
115


